Published in Ann Rheum Dis on June 01, 1997
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther (2006) 2.28
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study. Arthritis Res Ther (2006) 1.52
Lipoprotein profile in limited systemic sclerosis. Rheumatol Int (2005) 1.52
Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheumatol (2016) 1.42
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol (2013) 1.20
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis (2007) 1.14
Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag (2007) 1.08
Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am (2010) 1.06
Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis (1997) 1.06
A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol (2010) 1.03
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Rheumatoid arthritis and cardiovascular disease: an update on treatment issues. Curr Opin Rheumatol (2013) 0.87
A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role. Ther Adv Endocrinol Metab (2014) 0.82
Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther (2013) 0.81
Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis (2012) 0.80
Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease. Clin Rheumatol (2016) 0.78
Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken) (2015) 0.76
Lipid profiles in patients with rheumatoid arthritis. Ann Rheum Dis (1998) 0.75
Effects of Methotrexate in a Rabbit Model of In-Stent Neoatherosclerosis: An Optical Coherence Tomography Study. Sci Rep (2016) 0.75
Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induced diabetic rats. Indian J Pharmacol (2009) 0.75
Use of Hydroxychloroquine Is Associated With Improved Lipid Profile in Rheumatoid Arthritis Patients. J Clin Rheumatol (2017) 0.75
Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin. Indian J Pharmacol (2011) 0.75
Serum Lipid Alterations in Early Rheumatoid Arthritis Patients on Disease Modifying Anti Rheumatoid Therapy. Indian J Clin Biochem (2016) 0.75
Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy. Biomed Res Int (2014) 0.75
How to ensure that guidelines are effective. BMJ (1995) 4.31
Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia. Anesthesiology (1996) 3.65
The effects of explicit timing and feedback on compositional response rate in elementary school children. J Appl Behav Anal (1974) 3.56
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
Malignant melanoma in Scotland 1979-1983. Lancet (1985) 2.30
Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91. BMJ (1992) 2.14
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev (2007) 2.03
Antidepressants and side effects. Aust N Z J Psychiatry (1995) 2.02
Cutting waiting lists. BMJ (1991) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol (1991) 1.98
Antiprostaglandin synthetase activity of nonsteroidal anti-inflammatory drugs and gastrointestinal micro-bleeding: a comparison of flurbiprofen with benoxaprofen. Ann Rheum Dis (1981) 1.97
Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost (2007) 1.89
Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) (1986) 1.88
Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev (2007) 1.82
Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur J Biochem (1993) 1.77
Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun (1994) 1.75
Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry (1994) 1.73
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Post-irradiation morphoea. Br J Dermatol (1989) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Serum uric acid in acute gout. Ann Rheum Dis (1997) 1.68
Leg wound complications associated with coronary revascularization. J Thorac Cardiovasc Surg (1981) 1.67
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Granulomatous orchitis. Br J Urol (1968) 1.62
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59
Xanthomatosis secondary to lymphoedema. Trans St Johns Hosp Dermatol Soc (1970) 1.59
A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol (1999) 1.57
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.57
Circular chloroplast DNA from Euglena gracilis. Proc Natl Acad Sci U S A (1971) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Neurological abnormalities following open-heart surgery. J Thorac Cardiovasc Surg (1969) 1.48
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry (1994) 1.45
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2001) 1.44
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The treatment of plantar warts in the home. A critical appraisal of a new preparation. Practitioner (1971) 1.42
Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ (1988) 1.41
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Fibrin-ring granulomas: a non-specific reaction to liver injury? Histopathology (1991) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Availability of condoms in district general hospitals. BMJ (1990) 1.39
Rupture of an otherwise normal aortic valve. Report of two cases and review of the literature. J Thorac Cardiovasc Surg (1968) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
The dermatology out-patient service: a study of out-patient referrals in a Scottish population. Br J Dermatol (1984) 1.38
Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur J Biochem (1993) 1.37
Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol (1986) 1.36
Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol (1990) 1.36
Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet (1989) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2001) 1.33
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev (2003) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
Seventeen-year experience with routine shunting in carotid artery surgery. World J Surg (1979) 1.28
Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J Bacteriol (1992) 1.26
Genito-urinary tract injuries of civil hostilities. Br J Surg (1981) 1.26
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
En bloc resection of colon cancer adherent to other organs. Am J Surg (1987) 1.23
A neutral protease in rheumatoid synovial fluid capable of attacking the telopeptide regions of polymeric collagen fibrils. Biochim Biophys Acta (1975) 1.23
Canadian physicians may hear footsteps of change as US tiptoes toward health care reform. CMAJ (1994) 1.21
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming. Br J Cancer (2005) 1.21
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Giant hogweed dermatitis. Scott Med J (1970) 1.19
Synthesis of macromolecules during induction of haemoglobin synthesis by erythropoietin. J Mol Biol (1969) 1.18
Geriatric rehabilitation following fractures in older people: a systematic review. Health Technol Assess (2000) 1.18
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc Natl Acad Sci U S A (1993) 1.17
Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer (1994) 1.16
Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis (1988) 1.16
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2000) 1.14